Beauty Health (SKIN) Competitors $1.66 +0.04 (+2.47%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SKIN vs. ME, HLLY, EMBK, MDXG, LQDA, EMBC, EYE, CATX, IRMD, and KIDSShould you be buying Beauty Health stock or one of its competitors? The main competitors of Beauty Health include 23andMe (ME), Holley (HLLY), Embark Technology (EMBK), MiMedx Group (MDXG), Liquidia (LQDA), Embecta (EMBC), National Vision (EYE), Perspective Therapeutics (CATX), Iradimed (IRMD), and OrthoPediatrics (KIDS). Beauty Health vs. 23andMe Holley Embark Technology MiMedx Group Liquidia Embecta National Vision Perspective Therapeutics Iradimed OrthoPediatrics 23andMe (NASDAQ:ME) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk. Which has preferable valuation and earnings, ME or SKIN? Beauty Health has higher revenue and earnings than 23andMe. Beauty Health is trading at a lower price-to-earnings ratio than 23andMe, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio23andMe$219.64M0.52-$666.70M-$26.20-0.18Beauty Health$398M0.52-$100.12M-$0.83-2.00 Does the media prefer ME or SKIN? In the previous week, 23andMe and 23andMe both had 8 articles in the media. Beauty Health's average media sentiment score of 0.89 beat 23andMe's score of -0.08 indicating that Beauty Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 23andMe 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Beauty Health 2 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, ME or SKIN? 23andMe has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, Beauty Health has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Is ME or SKIN more profitable? Beauty Health has a net margin of -22.86% compared to 23andMe's net margin of -317.03%. Beauty Health's return on equity of -4.57% beat 23andMe's return on equity.Company Net Margins Return on Equity Return on Assets 23andMe-317.03% -83.22% -51.12% Beauty Health -22.86%-4.57%-0.37% Does the MarketBeat Community prefer ME or SKIN? Beauty Health received 28 more outperform votes than 23andMe when rated by MarketBeat users. However, 60.00% of users gave 23andMe an outperform vote while only 46.51% of users gave Beauty Health an outperform vote. CompanyUnderperformOutperform23andMeOutperform Votes1260.00% Underperform Votes840.00% Beauty HealthOutperform Votes4046.51% Underperform Votes4653.49% Do institutionals and insiders hold more shares of ME or SKIN? 36.1% of 23andMe shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 26.3% of 23andMe shares are held by company insiders. Comparatively, 41.0% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts rate ME or SKIN? 23andMe currently has a consensus price target of $9.40, suggesting a potential upside of 102.15%. Beauty Health has a consensus price target of $2.46, suggesting a potential upside of 48.09%. Given 23andMe's higher possible upside, equities research analysts clearly believe 23andMe is more favorable than Beauty Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 23andMe 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Beauty Health 3 Sell rating(s) 7 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.82 SummaryBeauty Health beats 23andMe on 12 of the 17 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Beauty Health News Delivered to You Automatically Sign up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SKIN vs. The Competition Export to ExcelMetricBeauty HealthSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$205.87M$4.45B$5.32B$8.52BDividend YieldN/A41.87%5.07%4.13%P/E Ratio-2.0043.38127.5316.08Price / Sales0.5261.401,490.6892.20Price / CashN/A49.3439.5134.18Price / Book3.464.264.765.07Net Income-$100.12M$11.52M$118.77M$225.46M7 Day Performance0.61%1.16%-0.38%0.06%1 Month Performance17.73%1.98%6.06%3.93%1 Year Performance-58.08%33.87%38.14%32.50% Beauty Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SKINBeauty Health2.9254 of 5 stars$1.66+2.5%$2.46+48.1%-58.1%$205.87M$398M-2.001,030ME23andMe1.9247 of 5 stars$5.04+3.9%$9.40+86.5%-71.6%$123.53M$219.64M-0.19770Gap DownHLLYHolley4.0898 of 5 stars$2.76-1.8%$6.54+136.8%-37.2%$330.59M$659.70M14.531,633Upcoming EarningsNews CoveragePositive NewsGap DownEMBKEmbark TechnologyN/A$2.88flatN/AN/A$69.26MN/A-0.37329MDXGMiMedx Group4.0266 of 5 stars$5.92+1.0%$12.00+102.7%+7.4%$873.82M$340.46M10.57870Analyst UpgradeAnalyst RevisionNews CoverageLQDALiquidia3.8771 of 5 stars$10.96-0.6%$24.67+125.1%+66.6%$841.66M$14.84M-6.9850Upcoming EarningsEMBCEmbecta1.1747 of 5 stars$14.58+3.2%$12.00-17.7%-6.1%$840.83M$1.12B12.152,200Short Interest ↑EYENational Vision3.6971 of 5 stars$10.14+1.8%$15.25+50.4%-29.4%$796.61M$2.16B-9.8413,998Upcoming EarningsShort Interest ↑CATXPerspective Therapeutics3.0104 of 5 stars$11.85-0.5%$20.63+74.1%N/A$737.82M$1.43M0.00116Gap UpIRMDIradimed4.8625 of 5 stars$52.67+1.2%$60.00+13.9%+17.6%$667.01M$69.48M36.08110Dividend AnnouncementNews CoverageKIDSOrthoPediatrics4.0912 of 5 stars$25.97-0.6%$40.00+54.0%+11.1%$618.84M$175.07M-23.83200Upcoming Earnings Related Companies and Tools Related Companies ME Alternatives HLLY Alternatives EMBK Alternatives MDXG Alternatives LQDA Alternatives EMBC Alternatives EYE Alternatives CATX Alternatives IRMD Alternatives KIDS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SKIN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Beauty Health Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Beauty Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
